Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Bertolotto A, Capobianco M, Amato M P, Capello E, Capra R, Centonze D, di Ioia M, Gallo A, Grimaldi L, Imberti L, et al.